A pharma client with a therapy for the disease sought to accelerate identification of patients. The client had a sponsored
genetic test to confirm diagnosis of hATTR amyloidosis. They partnered with an Advanced Analytics company to develop
a model to identify patients likely to have hATTR amyloidosis so they could be administered the genetic test. To train and
validate this model, the client needed a cohort of patients who had already taken the test, with their test results linked to
their medical and pharmacy claims.